The number of US individuals receiving treatment for diabetes doubled to about 19 million (8.5% of the population) in 2007 compared with 9.1 million (4.6% of the population) in 1996, according to a new report from the Agency for Healthcare Research and Quality.
Along with substantial increases in the numbers of individuals treated for diabetes have come substantial increases in the costs of the disorder, for both the country and affected individuals. Based on data from the Medical Panel Expenditure Survey, a nationally representative survey of the noninstitutionalized US population that is sponsored by AHRQ and the National Center for Health Statistics, spending on diabetes increased during the same period, from $18.5 billion to $40.8 billion.
Kuehn BM. Diabetes Treatment Doubles. JAMA. 2011;305(8):770. doi:10.1001/jama.2011.182
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: